ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company will attend the 2011 American Orthopaedic Foot & Ankle Society (AOFAS) Meeting in Keystone, Colorado July 13-16 to share product overviews for the company’s product innovations for foot and ankle surgeons. Additionally, surgical training sessions will be conducted on Wright’s state-of-the-art Mobile Medical Education Unit. The Wright Medical booth (#115) at the Keystone Convention Center will feature the following foot and ankle products:
PROPHECY® INBONE® Total Ankle System
The PROPHECY® INBONE® Total Ankle System, the industry’s first pre-operative navigation system for total ankle arthroplasty, will be previewed at Wright’s booth. This device is intended to provide surgeons with CT generated, patient-matched alignment guides for the INBONE® implant systems. Wright developed and has utilized the PROPHECY® Pre-Operative Navigation technology for the ADVANCE® Total Knee Replacement system since 2009. The PROPHECY® INBONE® Total Ankle System is pending 510(k) clearance and is not available for sale in the United States.
INBONE® II Total Ankle System
The INBONE® II System builds upon the core principles that have made the original INBONE® system successful, such as implant modularity and intramedullary-guided instrumentation for surgical accuracy and reproducibility. The INBONE® II System, when combined with the original INBONE® system, is the only ankle replacement on the U.S. market that offers surgeons multiple implant options with different articular geometries. These highly anatomic implants are intended to permit the surgeon to choose the appropriate amount of implant constraint or motion based upon the patient's unique anatomical demands. Improvements in the INBONE® II instrumentation are also intended to permit the surgeon to optimally place the implant components based upon each patient's biomechanical profile.
PRO-TOE™ VO Hammertoe Fixation System
The PRO-TOE™ VO Hammertoe System was designed to offer a simple and efficient means to surgically repair the lesser toes following correction of a hammertoe deformity. The internal design of the PRO-TOE™ VO implant eliminates the need for external wires, which has been the standard of care for many years. The implant is fabricated from stainless steel which simplifies the procedure by eliminating the freezer storage and special instruments required for other implant alternatives. Additionally, the system arrives in the operating room as a single, sterile-packed unit which has increased the efficiency of the procedure while removing costly cleaning and processing of a standard reusable instrument set.
ORTHOLOC™ Ankle Fracture System
The ORTHOLOC® 3Di Ankle Fracture System is a comprehensive single tray ankle fracture solution designed to address a wide range of fracture types and classifications. Employing the highly versatile ORTHOLOC™ 3Di polyaxial locking technology, this system provides the surgeon with multiple anatomic implant solutions and a comprehensive set of instrumentation. This technology, coupled with the single tray design, decreases logistical complications in the O.R., and enables the surgeon to match the appropriate implant construct with the patient and fracture type.
FUSIONFLEX™ Demineralized Moldable Scaffold
FUSIONFLEX™ Demineralized Moldable Scaffold is a unique form of demineralized bone matrix made from 100% allograft. It is designed for use in orthopaedic bone grafting applications. FUSIONFLEX™ scaffold quickly hydrates and becomes a flexible, absorbent matrix which is easily compressed to fit into challenging spaces, yet robust enough to expand to match nearly any contour within the space.
Additional featured products from Wright’s portfolio of leading foot and ankle solutions include the CHARLOTTE®family of reconstructive implants, DARCO® Locked Plating Systems, ORTHOLOC™ Polyaxial Locking Plating Systems, the BIOARCH® Subtalar Implant, SIDEKICK® External Fixators, ALLOPURE® and BIOFOAM® Osteotomy Wedge Systems, DART-FIRE® Small Screw Systems, GRAFTJACKET® Regenerative Tissue Matrix and the VALOR® Hindfoot Fusion Nail.
Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Company’s website at www.wmt.com.
This press release contains "forward-looking statements" as defined under U.S. federal securities laws. These statements reflect management’s current knowledge, assumptions, beliefs, estimates, and expectations and express management’s current views of future performance, results, and trends and may be identified by their use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," and other similar terms. Forward-looking statements are subject to a number of risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements. Such risks and uncertainties include the impact of Wright's settlement of the federal investigation into Wright's consulting arrangements with orthopaedic surgeons relating to its hip and knee products in the United States, including Wright's compliance with a Deferred Prosecution Agreement through September 2011 and a Corporate Integrity Agreement through September 2015, and those risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010, under the heading, “Risk Factors” and in Item 1A of Part II of our 10-Qs filed during 2011). Readers should not place undue reliance on forward-looking statements. Such statements are made as of the date of this press release, and we undertake no obligation to update such statements after this date.